Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Shepherd

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponadeE A Maher, F A Shepherd, T J Todd
Seminars in Oncology|December 1, 1996
Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancerF A Shepherd, J Latreille, K Paul, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2000
Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinomaE T Hsieh, F A Shepherd, M S Tsao
Canadian Medical Association Journal|July 7, 1979
Clinical use of blood, blood components and blood productsM A Blajchman, F A Shepherd, R A Perrault
The New England Journal of Medicine|April 3, 1999
Human herpesvirus 8 and renal transplantationC S Rabkin, F A Shepherd, J A Wade
Journal of the National Cancer Institute|January 1, 1992
Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials GroupF A Shepherd, P E Goss, J Rusthoven, et al.
Contemporary Clinical Trials|February 19, 2008
Validation of treatment induced specific adverse effect as a predictor of treatment benefit: a case study of NCIC CTG BR21K Ding, J Pater, M Whitehead, et al.
Archives of Internal Medicine|May 1, 1985
Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancerF A Shepherd, B Hoffert, W K Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2019
A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancerR J Kelly, F A Shepherd, A Krivoshik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin productionE W Winquist, J Laskey, M Crump, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponadeE A Maher, F A Shepherd, T J Todd
Seminars in Oncology|December 1, 1996
Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancerF A Shepherd, J Latreille, K Paul, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2000
Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinomaE T Hsieh, F A Shepherd, M S Tsao
Canadian Medical Association Journal|July 7, 1979
Clinical use of blood, blood components and blood productsM A Blajchman, F A Shepherd, R A Perrault
The New England Journal of Medicine|April 3, 1999
Human herpesvirus 8 and renal transplantationC S Rabkin, F A Shepherd, J A Wade
Journal of the National Cancer Institute|January 1, 1992
Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials GroupF A Shepherd, P E Goss, J Rusthoven, et al.
Contemporary Clinical Trials|February 19, 2008
Validation of treatment induced specific adverse effect as a predictor of treatment benefit: a case study of NCIC CTG BR21K Ding, J Pater, M Whitehead, et al.
Archives of Internal Medicine|May 1, 1985
Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancerF A Shepherd, B Hoffert, W K Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2019
A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancerR J Kelly, F A Shepherd, A Krivoshik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin productionE W Winquist, J Laskey, M Crump, et al.
Pageof 18